Rosenbaum Jay D. Abbott Laboratories Transaction History

Rosenbaum Jay D.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 9.09%	2,000 $237,000
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $254,166 - $311,212	2,200 New	2,200 $310,000
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $394,905 - $439,622	-5,030 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $204,600 - $221,850	-2,500 Reduced 33.2%	5,030 $421,000
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $14,576 - $17,000	-200 Reduced 2.59%	7,530 $633,000
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $46,056 - $50,832	-800 Reduced 9.38%	7,730 $471,000
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $344,935 - $389,990	-6,130 Reduced 41.81%	8,530 $511,000
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $704,559 - $786,362	14,660	14,660 $782,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

Stay updated on Rosenbaum Jay D. with notifications on news.